Position in MRK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$68,862,055
-$24,373,042 QoQ
Shares Held
572,467
-35.4% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Derivatives in MRK
reported options exposure · as of Jun 30, 2022CallValue
$68,240,745
CallShares
748,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Holocene Advisors, LP holds $1,499,965,087 across 7 Drug Manufacturers - General names. MRK ranks #5 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,662,887 | $525,174,574 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
2,611,826 | $364,010,189 | |
| 3 | GSK |
GSK plc
|
5,518,433 | $304,562,317 | |
| 4 | LLY |
ELI LILLY & Co
|
187,359 | $172,327,187 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
572,467 | $68,862,055 | |
| 6 | NVO |
Novo Nordisk A S
|
1,745,580 | $64,150,065 | |
| 7 | BIIB |
Biogen Inc.
|
4,793 | $878,700 |
All Filings in MRK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $68,862,055 | 572,467 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $93,235,097 | 885,760 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $54,219,703 | 646,011 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $13,421,004 | 149,521 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $307,816,691 | 2,486,403 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $258,094 | 1,956 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $51,333,702 | 470,865 | Shares | Sole | 2024-02-14 | |
| 2022-09-30 | $136,771,478 | 1,588,150 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $196,019,876 | 2,150,048 | Shares | Sole | 2022-08-15 | |
| 2022-06-30 | $68,240,745 | 748,500 | Call | Sole | 2022-08-15 | |
| 2022-03-31 | $151,871,350 | 1,850,961 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||